CA2987787C — Compositions for the improvement of distance vision and the treatment of refractive errors of the eye
Assigned to Lenz Therapeutics Inc · Expires 2023-06-27 · 3y expired
What this patent protects
The invention provides compositions and methods for the improvement of distance vision. The invention further provides compositions and methods for the treatment of refractive errors of the eye, such as presbyopia. The invention further provides ophthalmological compositions that…
USPTO Abstract
The invention provides compositions and methods for the improvement of distance vision. The invention further provides compositions and methods for the treatment of refractive errors of the eye, such as presbyopia. The invention further provides ophthalmological compositions that comprise from about 1.35% to about 2.0% w/v of aceclidine and from about 2.25% to about 2.75% w/v of a polyol.
Drugs covered by this patent
- Alphagan (BRIMONIDINE TARTRATE) · Senju Pharmaceutical Co., Ltd
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.